Advertisement

ADVERTISEMENT

d735

News
Ruxolitinib Cream Shows Anti-inflammatory and Antipruritic Efficacy for the Treatment of Atopic Dermatitis
05/20/2021
Ruxolitinib cream is well tolerated with potent anti-inflammatory and antipruritic efficacy for the treatment of atopic dermatitis, according to a recent study.
Ruxolitinib cream is well tolerated with potent anti-inflammatory and antipruritic efficacy for the treatment of atopic dermatitis, according to a recent study.
Ruxolitinib cream is well...
05/20/2021
The Dermatologist
News
Oral Abrocitinib Monotherapy Improves Patient-Reported Symptoms and QOL in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
05/20/2021
Abrocitinib showed a favorable safety profile for adult and adolescent patients with moderate to severe atopic dermatitis (AD) in phase 2b and 3 trials.
Abrocitinib showed a favorable safety profile for adult and adolescent patients with moderate to severe atopic dermatitis (AD) in phase 2b and 3 trials.
Abrocitinib showed a favorable...
05/20/2021
The Dermatologist
News
Inflammatory Marker TH2 Associated With Vascular Inflammation in Moderate to Severe AD
04/28/2021
An enhanced response of the inflammatory marker TH2 is associated with vascular inflammation in moderate to severe AD.
An enhanced response of the inflammatory marker TH2 is associated with vascular inflammation in moderate to severe AD.
An enhanced response of the...
04/28/2021
The Dermatologist
News
Atopic Dermatitis Associated With Learning Problems in Children
04/28/2021
Children with mild, moderate, or severe atopic dermatitis are more likely to have a learning disability than those with clear skin.
Children with mild, moderate, or severe atopic dermatitis are more likely to have a learning disability than those with clear skin.
Children with mild, moderate, or...
04/28/2021
The Dermatologist
News
Air Pollution From Wildfires Associated With Increased Health Care Use for AD and Itch
04/28/2021
Short-term exposure to poor air quality due to wildfires is associated with skin conditions in pediatric and adult patients
Short-term exposure to poor air quality due to wildfires is associated with skin conditions in pediatric and adult patients
Short-term exposure to poor air...
04/28/2021
The Dermatologist
News
Interdisciplinary Care Needed in Patients With Dermatologic and Irritable Bowel Diseases
04/13/2021
A recent study published in the Journal of Clinical Medicine examined the temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease (IBD).
A recent study published in the Journal of Clinical Medicine examined the temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease (IBD).
A recent study published in the...
04/13/2021
The Dermatologist
News
Abrocitinib Improves Moderate to Severe Atopic Dermatitis in Adults
04/13/2021
Abrocitinib improved symptoms and disease impacts in adults with moderate to severe atopic dermatitis (AD), according to results from a phase 2b study published in Dermatitis.
Abrocitinib improved symptoms and disease impacts in adults with moderate to severe atopic dermatitis (AD), according to results from a phase 2b study published in Dermatitis.
Abrocitinib improved symptoms...
04/13/2021
The Dermatologist
News
Increased School Absenteeism Associated with Atopic Dermatitis
03/24/2021
A cross-sectional study determined that children with atopic dermatitis (AD) had increased chronic school absenteeism vs children with psoriasis, finding an increased burden on quality of life in these patients.
A cross-sectional study determined that children with atopic dermatitis (AD) had increased chronic school absenteeism vs children with psoriasis, finding an increased burden on quality of life in these patients.
A cross-sectional study...
03/24/2021
The Dermatologist
News
Herpes Infection Low, Ocular Complications Most Common With Dupliumab Use
03/19/2021
A retrospective analysis found that ocular complications are most commonly associated with dupliumab use and that herpes infection is low.
A retrospective analysis found that ocular complications are most commonly associated with dupliumab use and that herpes infection is low.
A retrospective analysis found...
03/19/2021
The Dermatologist
News
Dupilumab Persistence High Among Adults With Atopic Dermatitis
02/26/2021
A study published in Annals of Allergy, Asthma & Immunology found that dupilumab persistence was high after 1 year in adults with atopic dermatitis (AD).
A study published in Annals of Allergy, Asthma & Immunology found that dupilumab persistence was high after 1 year in adults with atopic dermatitis (AD).
A study published in Annals of...
02/26/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use